glutamic acid has been researched along with bms204352 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boissard, CG; Cook, DA; Dworetzky, SI; Frantz, SW; Gribkoff, VK; Heman, K; Hewawasam, P; Hibbard, JR; Huston, K; Johnson, G; Kinney, GG; Krishnan, BS; Lombardo, LA; Meanwell, NA; Molinoff, PB; Moon, SL; Myers, RA; Ortiz, A; Pajor, L; Pieschl, RL; Post-Munson, DJ; Signor, LJ; Srinivas, N; Starrett, JE; Taber, MT; Thalody, G; Trojnacki, JT; Wiener, H; Yeleswaram, K; Yeola, SW | 1 |
1 other study(ies) available for glutamic acid and bms204352
Article | Year |
---|---|
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.
Topics: Animals; Brain; Calcium; Cell Line; CHO Cells; Cricetinae; Disease Models, Animal; Dogs; Glutamic Acid; Humans; In Vitro Techniques; Indoles; Large-Conductance Calcium-Activated Potassium Channels; Male; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Rats, Wistar; Safety; Stroke; Synaptic Transmission | 2001 |